Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review

Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review

Shimaa Aboelbaha,1 Monica Zolezzi,2 Hazem Elewa2 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar; 2Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha, QatarCorrespondence: Monica ZolezziCollege of Pharmacy, QU Health, Qatar University, Doha, QatarEm...

Full description

Bibliographic Details
Main Authors:	Aboelbaha S, Zolezzi M, Elewa H
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-07-01
Series:	Neuropsychiatric Disease and Treatment
Subjects:	pharmacogenetic testing major depressive disorder clinical decision support antidepressant treatment response
Online Access:	https://www.dovepress.com/effect-of-pharmacogenetic-based-decision-support-tools-in-improving-de-peer-reviewed-fulltext-article-NDT

Similar Items

Pharmacogenetics of antidepressant drugs: An update
by: Crisafulli Concetta, et al.
Published: (2014-01-01)

Pharmacogenetics of antidepressants
by: Concetta eCrisafulli, et al.
Published: (2011-02-01)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
by: L. K. Khokhlov, et al.
Published: (2019-05-01)

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
by: Víctor Pérez, et al.
Published: (2017-07-01)

Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies
by: Silvia Vilches, et al.
Published: (2019-09-01)

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action
by: Taichi Ochi, et al.
Published: (2021-07-01)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
by: Céline K. Stäuble, et al.
Published: (2021-07-01)

Exploring a Laboratory Model of Pharmacogenetics as Applied to Clinical Decision Making
by: David F. Kisor, et al.
Published: (2013-01-01)

Exploring a Laboratory Model of Pharmacogenetics as Applied to Clinical Decision Making
by: Angela Smith, PharmD Candidate, et al.
Published: (2013-01-01)

Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
by: Kristi Krebs, et al.
Published: (2019-08-01)

A Study of Antidepressant Prescription in Major Depressive Disorders in the Out-Patient Psychiatric Department of Siriraj Hospital
by: Somporn Wipisamakul, et al.
Published: (2005-08-01)

Pharmacogenetics of antidepressant response: An update
by: Drago Antonio, et al.
Published: (2009-04-01)

Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
by: Cornelis F. Vos, et al.
Published: (2021-10-01)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
by: Jing An, et al.
Published: (2019-12-01)

Improvement in Quality of Life With Left Prefrontal Transcranial Magnetic Stimulation in Patients With Pharmacoresistant Major Depression: Acute and Six Month Outcomes
by: H.B. Solvason, et al.
Published: (2014-03-01)

Taking the perspective that a depressive state reflects inflammation: implications for the use of antidepressants
by: Jill Leslie Littrell
Published: (2012-08-01)

Design and Implementation of Antidepressant Decision Making Aids
by: Beth DeJongh, et al.
Published: (2012-01-01)

Design and Implementation of Antidepressant Decision Making Aids
by: Beth DeJongh, Pharm.D., BCPS, et al.
Published: (2012-01-01)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Caroline Kamp Jørgensen, et al.
Published: (2021-08-01)

Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: A review
by: Jared L. Moreines, et al.
Published: (2011-01-01)

Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder
by: Rafał Świechowski, et al.
Published: (2019-06-01)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
by: Kristina A. Malsagova, et al.
Published: (2020-12-01)

FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy
by: Rossana Roncato, et al.
Published: (2019-04-01)

Leveraging the utility of pharmacogenomics in psychiatry through clinical decision support: a focus group study
by: Andrew Goodspeed, et al.
Published: (2019-08-01)

The pharmacological management of depression – Update 2017
by: Elzbieta Osuch, et al.
Published: (2017-03-01)

FKBP5 Gene Variants as Predictors for Antidepressant Response in Individuals with Major Depressive Disorder Who Have Experienced Childhood Trauma. A Systematic Review
by: Natalie Wietfeldt
Published: (2020-05-01)

Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review
by: Johanna Raymond, et al.
Published: (2021-01-01)

Pharmacological Treatments for Patients with Treatment-Resistant Depression
by: Valerie L. Ruberto, et al.
Published: (2020-06-01)

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study
by: Philip G. Janicak, et al.
Published: (2010-10-01)

Identification de biomarqueurs génétiques de réponse à la venlafaxine dans une cohorte de patients déprimés
by: Taranu, Adela
Published: (2017)

Cognitive impairment in depression: recent advances and novel treatments
by: Perini G, et al.
Published: (2019-05-01)

The utility of pharmacogenetic testing to support the treatment of bipolar disorder
by: Ielmini M, et al.
Published: (2018-03-01)

Primary care and mental health providers’ perceptions of implementation of pharmacogenetics testing for depression prescribing
by: Bonnie M. Vest, et al.
Published: (2020-10-01)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
by: Amy L. Pasternak, et al.
Published: (2020-10-01)

Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder
by: Dinyadarshini Johnson, et al.
Published: (2021-05-01)

The effects of physiotherapy methods combined with respiratory and relaxation exercises on patients with major depression
by: Elisa Calisgan, et al.
Published: (2020-12-01)

Development of a Strategic Tool for Shared Decision-Making in the Use of Antidepressants among Patients with Major Depressive Disorder: A Focus Group Study
by: Syahrir Zaini, et al.
Published: (2018-07-01)

How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist
by: Bernardo Dell’Osso, et al.
Published: (2020-10-01)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_miu2p8nd04l4uecrb295t5g7ef